We are live on ! Find out more
PVCT

PROVECTUS BIOPHARMACEUTICALS, INC. (DE)
PVCT

Delisted

PVCT was delisted on the 13th of October, 2016.

Back to rankings

7 hedge funds and large institutions have $21.9K invested in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more capital invested

Capital invested by funds: $18.2K → $21.9K (+$3.7K)

17% more funds holding

Funds holding: 6 → 7 (+1)

Holders
7
Holders Change
+1
Holders Change %
+16.67%
% of All Funds
0.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
HFBOT
1
Home Federal Bank of Tennessee
Tennessee
$9.6K – – –
LDB
2
Lee, Danner & Bass
Tennessee
$5K – – –
AW
3
Atlas Wealth
Ohio
$2.25K – – –
LIA
4
LBMC Investment Advisors
Tennessee
$2.11K – – –
ACM
5
Academy Capital Management
Texas
$1.92K – – –
FS
6
Financial Symmetry
North Carolina
$978 +$978 +10,191 New

PVCT Hedge Fund Activity: Q4 2023 in Review

7 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) for Q4 2023, worth a combined $21.9K — up 20% from $18.2K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new PVCT positions and 0 closed out — a net gain of 1 holder — while 0 added to existing stakes and 0 trimmed.

  • 7 institutional investors held PROVECTUS BIOPHARMACEUTICALS, INC. (DE) (PVCT) as of Q4 2023, up from 6 in Q3 2023.
  • Funds reported $21.9K of PROVECTUS BIOPHARMACEUTICALS, INC. (DE) stock for Q4 2023, up 20% quarter-over-quarter.
  • 1 fund opened new PROVECTUS BIOPHARMACEUTICALS, INC. (DE) positions in Q4 2023 and 0 closed out, a net change of +1 holder.

Based on aggregated 13F filings for Q4 2023.